$55.35
-0.31[-0.56%]
At close: Apr 25
Novonesis reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Novonesis using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | AM | NVZMY | Q1 | $0.41 | — | — | — | $666.31M | — | — | — | Get Alert |
02/01/2024 | AM | NVZMY | Q4 | $0.43 | $0.44 | $0.36 | -18.18% | $606.10M | $674.70M | $664.23M | -1.55% | Get Alert |
10/26/2023 | AM | NVZMY | Q3 | $0.56 | $0.42 | $0.49 | 16.67% | $591.68M | $634.28M | $650.51M | 2.56% | Get Alert |
08/09/2023 | AM | NVZMY | Q2 | $0.42 | $0.42 | $0.32 | -23.81% | $614.04M | $632.02M | $616.52M | -2.45% | Get Alert |
04/26/2023 | AM | NVZMY | Q1 | $0.45 | $0.44 | $0.41 | -6.82% | $659.40M | $662.60M | $666.31M | 0.56% | Get Alert |
01/26/2023 | AM | NVZMY | Q4 | $0.34 | $0.41 | $0.43 | 4.88% | $589.85M | $671.94M | $606.10M | -9.80% | Get Alert |
11/03/2022 | AM | NVZMY | Q3 | $0.48 | $0.62 | $0.56 | -9.68% | $596.04M | $622.40M | $591.68M | -4.93% | Get Alert |
08/11/2022 | AM | NVZMY | Q2 | $0.46 | — | $0.42 | — | $579.96M | — | $614.04M | — | Get Alert |
04/27/2022 | AM | NVZMY | Q1 | $0.51 | — | $0.45 | — | $611.99M | — | $659.40M | — | Get Alert |
02/01/2022 | AM | NVZMY | Q4 | $0.37 | $0.36 | $0.34 | -5.56% | $551.36M | $576.38M | $589.85M | 2.34% | Get Alert |
10/27/2021 | AM | NVZMY | Q3 | $0.40 | $0.40 | $0.48 | 20.00% | $538.67M | $582.09M | $596.04M | 2.40% | Get Alert |
08/12/2021 | AM | NVZMY | Q2 | $0.34 | — | $0.46 | — | $494.68M | — | $579.96M | — | Get Alert |
04/27/2021 | AM | NVZMY | Q1 | $0.42 | — | $0.51 | — | $558.41M | — | $611.99M | — | Get Alert |
02/02/2021 | AM | NVZMY | Q4 | $0.49 | — | $0.37 | — | $559.65M | — | $551.36M | — | Get Alert |
10/21/2020 | AM | NVZMY | Q3 | $0.33 | $0.63 | $0.40 | -36.51% | $555.60M | $289.03M | $538.67M | 86.37% | Get Alert |
08/12/2020 | AM | NVZMY | Q2 | $0.47 | — | $0.34 | — | $519.33M | — | $494.68M | — | Get Alert |
04/29/2020 | AM | NVZMY | Q1 | $0.37 | — | $0.42 | — | $529.83M | — | $558.41M | — | Get Alert |
01/23/2020 | AM | NVZMY | Q4 | $0.44 | — | $0.49 | — | $567.89M | — | $559.65M | — | Get Alert |
10/23/2019 | AM | NVZMY | Q3 | $0.41 | — | $0.33 | — | $548.70M | — | $555.60M | — | Get Alert |
Novonesis (NVZMY) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on February 1, 2024 for Q4.
The Actual EPS was $0.36, which missed the estimate of $0.44.
The Actual Revenue was $664.2M, which missed the estimate of $674.7M.
Browse earnings estimates, EPS, and revenue on all stocks.